Works matching IS 00070920 AND DT 2024 AND VI 131 AND IP 3

Results: 21

Correction: DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer.

Published in:

2024

By:

Hou, Pingfu;
Shi, Peicong;
Jiang, Tao;
Yin, Hang;
Chu, Sufang;
Shi, Meilin;
Bai, Jin;
Song, Jun

Publication type:

Correction Notice

Editorial Expression of Concern: Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.

Published in:

2024

By:

Khan, S.;
Aspe, J. R.;
Asumen, M. G.;
Almaguel, F.;
Odumosu, O.;
Acevedo-Martinez, S.;
De Leon, M.;
Langridge, W. H. R.;
Wall, N. R.

Publication type:

Correction Notice

Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.

Published in:

2024

By:

Río-Vilariño, Anxo;
García-Foncillas, Jesús;
Cebrián, Arancha

Publication type:

Letter

Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice.

Published in:

2024

By:

Waller, Cornelius F.;
Möbius, Julia;
Fuentes-Alburo, Adolfo

Publication type:

Correction Notice

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 601, doi. 10.1038/s41416-024-02760-1

By:

Roa, Paola;
Foglizzo, Valentina;
Harada, Guilherme;
Repetto, Matteo;
Kulick, Amanda;
de Stanchina, Elisa;
de Marchena, Michelle;
Auwardt, Supipi;
Sayed Ahmed, Shaza;
Bremer, Nicole Virginia;
Yang, Soo-Ryum;
Feng, Yangbo;
Zhou, Chao;
Kong, Norman;
Liang, Ruixia;
Xu, Haipeng;
Zhang, Bin;
Bardelli, Alberto;
Toska, Eneda;
Ventura, Andrea

Publication type:

Article

Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 468, doi. 10.1038/s41416-024-02758-9

By:

Schörghofer, David;
Vock, Laurenz;
Mirea, Madalina A.;
Eckel, Oliver;
Gschwendtner, Anna;
Neesen, Jürgen;
Richtig, Erika;
Hengstschläger, Markus;
Mikula, Mario

Publication type:

Article

Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 515, doi. 10.1038/s41416-024-02756-x

By:

Merrick, Sophie;
Rush, Hannah L.;
Daniels, Susanna;
Fielding, Alison;
Deveson Kell, Sharon;
Pickering, Lisa;
Langley, Ruth E.;
South, Annabelle;
Gilbert, Duncan C.

Publication type:

Article

Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 534, doi. 10.1038/s41416-024-02755-y

By:

Nagelberg, Amy L.;
Sihota, Tianna S.;
Chuang, Yu-Chi;
Shi, Rocky;
Chow, Justine L. M.;
English, John;
MacAulay, Calum;
Lam, Stephen;
Lam, Wan L.;
Lockwood, William W.

Publication type:

Article

DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 498, doi. 10.1038/s41416-024-02754-z

By:

Chan, Tsun Ho;
Zhang, J. Eunice;
Pirmohamed, Munir

Publication type:

Article

Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 589, doi. 10.1038/s41416-024-02752-1

By:

Sinha, Sutapa;
Guo, Ray;
Del Busso, Miles D.;
Han, Weiguo;
Boysen, Justin;
Wellik, Linda E.;
Ghosh, Asish K.;
Kay, Neil E.

Publication type:

Article

CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 444, doi. 10.1038/s41416-024-02750-3

By:

Liu, Xinlin;
Li, Wei;
Yi, Lu;
Wang, Jianxi;
Liu, Wentao;
Cheng, Hongtao;
Ren, Shangqing

Publication type:

Article

PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 577, doi. 10.1038/s41416-024-02749-w

By:

Qiu, Lipeng;
Li, Ruyan;
Wang, Yue;
Lu, Ziwen;
Tu, Zhigang;
Liu, Hanqing

Publication type:

Article

KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 524, doi. 10.1038/s41416-024-02746-z

By:

Budczies, Jan;
Romanovsky, Eva;
Kirchner, Martina;
Neumann, Olaf;
Blasi, Miriam;
Schnorbach, Johannes;
Shah, Rajiv;
Bozorgmehr, Farastuk;
Savai, Rajkumar;
Stiewe, Thorsten;
Peters, Solange;
Schirmacher, Peter;
Thomas, Michael;
Kazdal, Daniel;
Christopoulos, Petros;
Stenzinger, Albrecht

Publication type:

Article

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 481, doi. 10.1038/s41416-024-02744-1

By:

Gulikers, Judith L.;
Otten, Leila-Sophie;
Hendriks, Lizza E. L.;
Winckers, Kristien;
Henskens, Yvonne;
Leentjens, Jenneke;
van den Heuvel, Michel M.;
ter Heine, Rob;
Croes, Sander;
Piet, Berber;
van Geel, Robin M. J. M.

Publication type:

Article

Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 430, doi. 10.1038/s41416-024-02742-3

By:

Zhang, Jin-Na;
Dong, Meng-Meng;
Cao, Wen;
Chen, Hao-Guang;
Gu, Hui-Yao;
Feng, Yi-Li;
Zhang, En-Fan;
He, Jing-Song;
Liu, Si-Cheng;
Xie, An-Yong;
Cai, Zhen

Publication type:

Article

Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 565, doi. 10.1038/s41416-024-02731-6

By:

Aronson, S. Lot;
Walker, Cédric;
Thijssen, Bram;
van de Vijver, Koen K.;
Horlings, Hugo M.;
Sanders, Joyce;
Alkemade, Maartje;
Koole, Simone N.;
Lopez-Yurda, Marta;
Lok, Christianne A. R.;
van Driel, W. J.;
Hermans, H. M.;
van Leeuwen, J. H. Schagen;
Schreuder, H. W. R.;
van Gent, M. D. J. M.;
van Ham, M. A. P. C.;
Arts, H. J. G.;
van Dam, P. A.;
Vuylsteke, P.;
Rottenberg, Sven

Publication type:

Article

Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 491, doi. 10.1038/s41416-024-02728-1

By:

Millen, Gerard C.;
Lawford, Alice;
Duncan, Catriona;
Jenkinson, Helen;
Veal, Gareth J.;
Barnett, Shelby

Publication type:

Article

The in vitro dynamics of pseudo-vascular network formation.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 457, doi. 10.1038/s41416-024-02722-7

By:

Oraiopoulou, Mariam-Eleni;
Couturier, Dominique-Laurent;
Bunce, Ellie V.;
Cannell, Ian G.;
Sweeney, Paul W.;
Naylor, Huw;
Golinska, Monika;
Hannon, Gregory J.;
Sakkalis, Vangelis;
Bohndiek, Sarah E.

Publication type:

Article

Metastasis-associated fibroblasts in peritoneal surface malignancies.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 407, doi. 10.1038/s41416-024-02717-4

By:

Ramos, Cristiano;
Gerakopoulos, Vasileios;
Oehler, Rudolf

Publication type:

Article

Anti-PEc: Development of a novel monoclonal antibody against prostate cancer.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 551, doi. 10.1038/s41416-024-02713-8

By:

Armakolas, Athanasios;
Alevizopoulos, Nektarios;
Stathaki, Martha;
Petraki, Constantina;
Agrogiannis, George;
Samiotaki, Martina;
Panayotou, George;
Chatzinikita, Eirini;
Koutsilieris, Michael

Publication type:

Article

The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 420, doi. 10.1038/s41416-024-02684-w

By:

Chen, Kaina;
Shuen, Timothy W. H.;
Chow, Pierce K. H.

Publication type:

Article